Here are four takeaways:
1. The company plans to use the funds for the next phase of pre-clinical testing for its BioMg 250 product.
2. BioMg 250 is a magnesium alloy used in orthopedic fixation devices.
3. The company has already conducted an animal trial for the BioMg 250 implants.
4. BioMg 250 implants are designed for numerous applications, including sports medicine procedures such as ACL, rotator cuff and foot and ankle repair.
More articles on devices:
Medtech, Life Spine, Zimmer Biomet & more: 20 key notes
Amedica’s product revenue drops 15% in 2015 to $19.5M: 7 key notes
Maxx Orthopedics’ Freedom PCK System successfully implanted in 1st surgeries: 4 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
